Minimum viable product is one of the most important inputs to developing a manufacturing process. It defines essentials that matter to the people who make the product.
- Strained Manufacturing, Complexity Stymie In Vivo Progress
- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- Ask The Pros — The Latest In HCP Monitoring
- Lessons In Quality From Sanofi's Plai.qa
- The Promise And Paradox Of QbD
- The Future Of Biotech Outsourcing: Essential Skills For Program Managers
- Hidden Sensitive Data Liability: Why Legacy Web Forms Put Life Sciences Organizations At Critical Risk
EDITOR'S DESK
-
The 9 Fastest-Growing Outsourcing Segments
Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.
At BioProcess International 2025, leaders from AbbVie and Amgen gave keynote presentations about how their companies are advancing product development through digital tools.
AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.
Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
GUEST COLUMNISTS
-
Strained Manufacturing, Complexity Stymie In Vivo Progress
Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.
-
To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.
-
Ask The Pros — The Latest In HCP Monitoring
Established methods focused on counting all HCPs indiscriminately. Now, a new wave of sophisticated monitoring offers clearer impurity profiles.
-
Lessons In Quality From Sanofi's Plai.qa
The platform orchestrates data to evaluate site maturity and performance and provide recommendations for improvement.
-
The Promise And Paradox Of QbD
The difference between QbD as burden and QbD as advantage lies in critical thinking supported by structure — a hierarchy of metrics, toolsets, and tailored platforms.
-
The Future Of Biotech Outsourcing: Essential Skills For Program Managers
The next generation of program managers who liaise with contract manufacturers needs an expanded skillset to thrive.
-
Hidden Sensitive Data Liability: Why Legacy Web Forms Put Life Sciences Organizations At Critical Risk
Many life science organizations collect sensitive data through outdated web forms, exposing companies to critical vulnerabilities, data breaches, regulatory penalties, and more.
-
A Hierarchy Of Metrics Brings Strategy Into Biopharma's Daily Work
Information now flows faster than organizations can think about it, and without deliberate structure, decision-making becomes reactive rather than reflective.
BIOPROCESSING WHITE PAPERS
-
Non-Viral Genetic Modification Using The 4D-Nucleofector LV Unit In CGT
This paper underscores the 4D-Nucleofector® LV Unit as a pivotal tool for translating genetic modification technologies into scalable, safe, and effective therapeutic solutions.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing3/25/2024
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.
-
Rethinking Peptones As First-Line Optimization Tools11/14/2025
Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.
-
The GxP Digital Maturity Model8/8/2025
Explore how the GMP Digital Maturity Model guides life sciences companies through five stages to improve compliance, efficiency, and profitability with strategic digital adoption.
-
The Impact Of Annex 1 (2022) On Sterility Assurance4/24/2025
Airflow visualization studies, crucial for GMP compliance, validate unidirectional airflow effectiveness in contamination control. Discover their enhanced role in quality by design and revised Annex 1 guidelines.
-
How Automation Is Driving Carbon Reduction10/21/2025
Manufacturers can cut emissions and boost efficiency by modernizing energy and utility systems. Explore how smart automation and analytics offer fast ROI and long-term sustainability.
BIOPROCESSING APP NOTES & CASE STUDIES
- AI Predictive Maintenance Prevents Batch Loss And Production Shutdown
- The Proven Supplement For CAR-T Solid Tumor Cytotoxicity
- Automation Of iPSC Culture, Passaging, And Expansion
- Biocompatibility Studies On CHO Cell Culture In X-ray Irradiated BioBLU® Single-Use Bioreactors
- Enhance Immuno-Oncology Research With Knock-Out Cell Lines
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
- Supporting The Next Generation Of ADCs
- AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing
- On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
- On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing
- On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.
- Single-Use Standardization Starts At Home
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles digs into the industry’s growing focus on knowledge management as an indispensable facet of biomanufacturing and pharmaceutical development, exploring how it plays into risk management, quality, vendor relationships, and supply chain resilience.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 12.09.25 -- The Future Of Biotech Outsourcing: Essential Skills For Program Managers
- 12.08.25 -- New Technical Insights To Elevate Your CDO Programs
- 12.08.25 -- Exploring The Benefits Of Electroporation In NK Cell Transfection
- 12.05.25 -- STREAM Edition: Lessons In Scaling Regenerative Medicine Manufacturing
- 12.05.25 -- ADCs: Advancements And Insights